Focusing on OB-OC-MΦ Axis and MiR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Aug 1

PMID 35909545

Authors

Tian-Liang Ma

Peng Zhu

Zhuo-Ran Ke

Jing-Xian Chen

Yi-He Hu

Jie Xie

Affiliations

Soon will be listed here.

Abstract

Osteoporosis is a bone metabolic disorder characterized by decreased bone density and deteriorated microstructure, which increases the risk of fractures. The imbalance between bone formation and bone resorption results in the occurrence and progression of osteoporosis. Osteoblast-mediated bone formation, osteoclast-mediated bone resorption and macrophage-regulated inflammatory response play a central role in the process of bone remodeling, which together maintain the balance of the osteoblast-osteoclast-macrophage (OB-OC-MΦ) axis under physiological conditions. Bone formation and bone resorption disorders caused by the imbalance of OB-OC-MΦ axis contribute to osteoporosis. Many microRNAs are involved in the regulation of OB-OC-MΦ axis homeostasis, with microRNA-23a (miR-23a) being particularly crucial. MiR-23a is highly expressed in the pathological process of osteoporosis, which eventually leads to the occurrence and further progression of osteoporosis by inhibiting osteogenesis, promoting bone resorption and inflammatory polarization of macrophages. This review focuses on the role and mechanism of miR-23a in regulating the OB-OC-MΦ axis to provide new clinical strategies for the prevention and treatment of osteoporosis.

Citing Articles

Recent advances of miR-23 in human diseases and growth development.

Qian X, Jiang Y, Yang Y, Zhang Y, Xu N, Xu B Noncoding RNA Res. 2025; 11:220-233.

PMID: 39896346 PMC: 11787465. DOI: 10.1016/j.ncrna.2024.12.010.

Network regulatory mechanism of ncRNA on the Wnt signaling pathway in osteoporosis.

An F, Meng X, Yuan L, Niu Y, Deng J, Li Z Cell Div. 2023; 18(1):3.

PMID: 36879309 PMC: 9990358. DOI: 10.1186/s13008-023-00086-7.

References

Matsuura T, Ichinose S, Akiyama M, Kasahara Y, Tachikawa N, Nakahama K . Involvement of CX3CL1 in the Migration of Osteoclast Precursors Across Osteoblast Layer Stimulated by Interleukin-1ß. J Cell Physiol. 2016; 232(7):1739-1745. DOI: 10.1002/jcp.25577. View

Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W . Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways. Oncogene. 2019; 39(2):428-442. DOI: 10.1038/s41388-019-0996-y. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

Chan J, Glass G, Ersek A, Freidin A, Williams G, Gowers K . Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response. EMBO Mol Med. 2015; 7(5):547-61. PMC: 4492816. DOI: 10.15252/emmm.201404487. View

Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D . miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 2015; 12(3):343-53. PMC: 4615895. DOI: 10.1080/15476286.2015.1017205. View

Gao Y, Morita I, Maruo N, Kubota T, Murota S, Aso T . Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation. Bone. 1998; 22(5):487-93. DOI: 10.1016/s8756-3282(98)00040-4. View

Canalis E, Mazziotti G, Giustina A, Bilezikian J . Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007; 18(10):1319-28. DOI: 10.1007/s00198-007-0394-0. View

Tian F, Ji X, Xiao W, Wang B, Wang F . CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression. Stem Cells Int. 2015; 2015:632305. PMC: 4345275. DOI: 10.1155/2015/632305. View

Strege D, KAHN A, Jeffrey J, Partridge N . Stimulation of collagenase production by rat osteosarcoma cells can occur in a subpopulation of cells. J Bone Miner Res. 1990; 5(9):963-71. DOI: 10.1002/jbmr.5650050910. View

10.

Mandal C, Ghosh Choudhury G, Ghosh-Choudhury N . Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology. 2009; 150(11):4989-98. PMC: 2775973. DOI: 10.1210/en.2009-0026. View

11.

Liu D, Yao S, Wise G . Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle. Eur J Oral Sci. 2006; 114(1):42-9. DOI: 10.1111/j.1600-0722.2006.00283.x. View

12.

Sun L, Wang N, Ban T, Sun Y, Han Y, Sun L . MicroRNA-23a mediates mitochondrial compromise in estrogen deficiency-induced concentric remodeling via targeting PGC-1α. J Mol Cell Cardiol. 2014; 75:1-11. DOI: 10.1016/j.yjmcc.2014.06.012. View

13.

Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon I, Nepomnaschy I . Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010; 5(2):e9252. PMC: 2821929. DOI: 10.1371/journal.pone.0009252. View

14.

Yin Y, Chen G, Gong L, Ge K, Pan W, Li N . DNAzyme-Powered Three-Dimensional DNA Walker Nanoprobe for Detection Amyloid β-Peptide Oligomer in Living Cells and in Vivo. Anal Chem. 2020; 92(13):9247-9256. DOI: 10.1021/acs.analchem.0c01592. View

15.

Li H, Zhai Z, Qu X, Xu J, Qin A, Dai K . MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases. Curr Drug Targets. 2016; 19(5):422-431. DOI: 10.2174/1389450117666160502144329. View

16.

Faulkner B, Astleford K, Mansky K . Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases. Molecules. 2019; 24(7). PMC: 6479495. DOI: 10.3390/molecules24071355. View

17.

Yunna C, Mengru H, Lei W, Weidong C . Macrophage M1/M2 polarization. Eur J Pharmacol. 2020; 877:173090. DOI: 10.1016/j.ejphar.2020.173090. View

18.

Horwood N . Macrophage Polarization and Bone Formation: A review. Clin Rev Allergy Immunol. 2015; 51(1):79-86. DOI: 10.1007/s12016-015-8519-2. View

19.

Raehtz S, Bierhalter H, Schoenherr D, Parameswaran N, McCabe L . Estrogen Deficiency Exacerbates Type 1 Diabetes-Induced Bone TNF-α Expression and Osteoporosis in Female Mice. Endocrinology. 2017; 158(7):2086-2101. PMC: 5505215. DOI: 10.1210/en.2016-1821. View

20.

Vandewalle J, Luypaert A, De Bosscher K, Libert C . Therapeutic Mechanisms of Glucocorticoids. Trends Endocrinol Metab. 2017; 29(1):42-54. DOI: 10.1016/j.tem.2017.10.010. View